¼¼°èÀÇ ¼ÒÈ­±â°ú ½ÃÀå : ¾àÁ¦º°, Á¦Çüº°, Áúȯº°, À¯Åëä³Îº°, Áö¿ªº°
Gastroenterology Market, By Drug Type, By Dosage Form, By Disease Type, By Distribution Channel, By Geography
»óǰÄÚµå : 1567271
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,385,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,933,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,191,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ¼ÒÈ­±â°ú ½ÃÀåÀº 2024³â 351¾ï 2,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2031³â¿¡´Â 531¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö 6.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼³»¿ë
±âÁس⵵ 2023³â 2024³â ½ÃÀå ±Ô¸ð 351¾ï 2,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£(2024-2031³â) CAGR: 6.10% 2031³â °¡Ä¡ ¿¹Ãø 531¾ï ´Þ·¯
±×¸². ¼ÒÈ­±â°ú ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Gastroenterology Market-IMG1

¼¼°è ¼ÒÈ­±â°ú ½ÃÀåÀº À§±Ë¾ç, ¿°Áõ¼º ÀåÁúȯ, °ú¹Î¼º ´ëÀåÁõÈıº µî ¼ÒÈ­±â Áúȯ Áõ°¡¿Í È¿°úÀûÀÎ Áø´Ü ¹× Ä¡·á ¼Ö·ç¼ÇÀ» ÇÊ¿ä·Î ÇÏ´Â ³ëÀÎ Àα¸ Áõ°¡°¡ ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ÒÈ­±â ³»½Ã°æ °Ë»ç ÀåºñÀÇ ±â¼ú ¹ßÀü°ú ¼ÒÈ­±â Áúȯ¿¡ ´ëÇÑ ½Å¾à ½ÃÀå °³Ã´µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù. ´Ù¾çÇÑ ½ÃÀå ±â¾÷µéÀÌ ÀÇ·á ½Ã¼³°ú ȯÀÚ Áõ°¡ÇÏ´Â ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ ½ÅÁ¦Ç° Ãâ½Ã¿Í »ç¾÷ È®Àå¿¡ Èû¾²°í ÀÖ½À´Ï´Ù. ¼±Áø ¼ÒÈ­±â ÀÇ·á±â±â¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë°ú Àú¼Òµæ ±¹°¡¿¡¼­ÀÇ ÀÎ½Ä ºÎÁ·Àº ȯÀÚµéÀÇ ÀÇ·á Á¢±Ù¼º È®´ë¿¡ °É¸²µ¹·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¼¼°è ¼ÒÈ­±â°ú ½ÃÀåÀÇ ¼ºÀåÀº Àü ¼¼°è ¼ÒÈ­±â ÁúȯÀÇ À¯º´·ü Áõ°¡, ¼ÒÈ­±â Áúȯ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡, ¼ÒÈ­±â ÀÇ·á±â±âÀÇ ¹ßÀü µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ±×·¯³ª À§Àå±â±¸ ¹× ³»½Ã°æ °Ë»ç Àåºñ¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. À§Àå Áúȯ¿¡ ´ëÇÑ »õ·Î¿î °æ±¸¿ë ÀǾàǰÀÇ ÃâÇö°ú ½ÅÈï±¹ ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó °³¹ßÀº ½ÃÀå È®´ëÀÇ ±âȸ°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¸¹Àº ȯÀÚ ¼ö, Çõ½ÅÀûÀÎ Ä¡·á¹ýÀÇ ½Å¼ÓÇÑ ½ÂÀÎ, ½ÃÀå ÁøÃâ±â¾÷ÀÇ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê ´öºÐ¿¡ ¼¼°è ¼ÒÈ­±â °úÇÐ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀº Áß±¹, Àεµ µîÀÇ ±¹°¡¿¡¼­ Àü¹® ÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÊ¿¡ µû¶ó ³ôÀº ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

(º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡)

ÀÌ º¸°í¼­´Â ¼¼°èÀÇ ¼ÒÈ­±â°ú ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2023³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.

±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¼ÒÈ­±â°ú ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.

ÀÌ Á¶»ç¿¡ Æ÷ÇÔµÈ ÁÖ¿ä ±â¾÷À¸·Î´Â Medtronic, Johnson & Johnson, Abbott Laboratories, Hoffmann-La Roche, Bayer AG, GlaxoSmithKline, Sanofi, Pfizer, Novartis AG µîÀÌ Æ÷ÇԵ˴ϴÙ.

ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¼ÒÈ­±â°ú ½ÃÀå ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¼ÒÈ­±â°ú ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¼ÒÈ­±â°ú ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¼ÒÈ­±â°ú ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2019³â-2031³â(10¾ï ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ ¼ÒÈ­±â°ú ½ÃÀå, Á¦Çüº°, 2019³â-2031³â(10¾ï ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ ¼ÒÈ­±â°ú ½ÃÀå, Áúȯ À¯Çüº°, 2019³â-2031³â(10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ ¼ÒÈ­±â°ú ½ÃÀå, À¯Åë ä³Îº°, 2019³â-2031³â,(10¾ï ´Þ·¯)

Á¦9Àå ¼¼°èÀÇ ¼ÒÈ­±â°ú ½ÃÀå, Áö¿ªº°, 2019³â-2031³â,(10¾ï ´Þ·¯)

  • ¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹

    Á¦10Àå °æÀï ±¸µµ

    • ±â¾÷ °³¿ä
      • Allied Digestive Health
      • Boston Scientific
      • Capital Digestive Care
      • CRH Medical
      • Iterative Scopes
      • Fujifilm Medical
      • Gastro Health
      • GI Alliance
      • Medtronic
      • Micro-Tech Endoscopy
      • Motus GI
      • Olympus
      • One GI
      • PE GI Solutions
      • Peak Gastroenterology Associates
      • Pentax Medical
      • Pinnacle GI Partners
      • Saneso
      • Surgical Innovations
      • Wision AI

    Á¦11Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

    • Wheel of Fortune
    • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
    • COM(Coherent Opportunity Map)

    Á¦12Àå Á¶»ç ¹æ¹ý

    • Âü°í ¹®Çå
    • Á¶»ç ¹æ¹ý
    LSH
  • ¿µ¹® ¸ñÂ÷

    ¿µ¹®¸ñÂ÷

    Global gastroenterology market is estimated to be valued at USD 35.12 Bn in 2024 and is expected to reach USD 53.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.

    Report Coverage Report Details
    Base Year: 2023 Market Size in 2024: US$ 35.12 Bn
    Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
    Forecast Period 2024 to 2031 CAGR: 6.10% 2031 Value Projection: US$ 53.10 Bn
    Figure. Gastroenterology Market Share (%), By Region, 2024
    Gastroenterology Market - IMG1

    Global gastroenterology market growth is driven by rising gastrointestinal disorders such as stomach ulcer, inflammatory bowel disease, irritable bowel syndrome and growing geriatric population that requires effective diagnosis and treatment solutions. Furthermore, technological advancements in gastrointestinal endoscopy devices along with development of novel drugs for gastrointestinal issues can also drive the market growth. Various market players are engaged in new product launches and expansions to cater to increasing needs of healthcare facilities as well as patients. High costs associated with advanced gastroenterology devices and lack of awareness in low-income nations can pose challenges for broader patient access to care.

    Market Dynamics:

    Global gastroenterology market growth is driven by factors like growing prevalence of gastrointestinal disorders worldwide, increasing geriatric population susceptible to digestive diseases, and advancements in gastrointestinal medical devices. However, high costs associated with gastrointestinal instrumentation and endoscopy devices can hamper the market growth. Emergence of novel oral medicines for gastrointestinal issues and developing healthcare infrastructure in emerging nations can present lucrative opportunities for market expansion. North America dominates the global gasteroenterology market, owing to sizable patient population, fast approval of innovative therapies, and strategic initiatives by market players. However, Asia Pacific is expected to offer high growth prospects due to improving access to specialty care in nations like China and India.

    (Key features of the study):

    This report provides in-depth analysis of the global gastroenterology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

    It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

    This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

    It profiles key players in the global gastroenterology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

    Key companies covered as a part of this study include Medtronic, Johnson & Johnson, Abbott Laboratories, Hoffmann-La Roche, Bayer AG, GlaxoSmithKline, Sanofi, Pfizer, and Novartis AG

    Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

    Global gastroenterology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

    Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gastroenterology market

    Detailed Segmentation-

    Table of Contents

    1. Research Objectives and Assumptions

    2. Market Purview

    3. Market Dynamics, Regulations, and Trends Analysis

    4. Global Gastroenterology Market - Impact of Coronavirus (COVID-19) Pandemic

    5. Global Gastroenterology Market, By Drug Type, 2019 - 2031, (USD Bn)

    6. Global Gastroenterology Market, By Dosage Form, 2019 - 2031, (USD Bn)

    7. Global Gastroenterology Market, By Disease Type, 2019 - 2031, (USD Bn)

    8. Global Gastroenterology Market, By Distribution Channel, 2019 - 2031, (USD Bn)

    9. Global Gastroenterology Market, By Region, 2019 - 2031, (USD Bn)

    10. Competitive Landscape

    11. Analyst Recommendations

    12. Research Methodology

    (ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
    ¨Ï Copyright Global Information, Inc. All rights reserved.
    PC¹öÀü º¸±â